Universal Health Realty Income Trust
General ticker "UHT" information:
- Sector: Real Estate
- Industry: REIT - Healthcare Facilities
- Capitalization: $542.5M (TTM average)
Universal Health Realty Income Trust follows the US Stock Market performance with the rate: 11.8%.
Estimated limits based on current volatility of 1.2%: low 42.62$, high 43.68$
Factors to consider:
- Earnings expected soon, date: 2026-02-25 bmo
- Company pays dividends (quarterly): last record date 2025-12-22, amount 0.74$ (Y6.90%)
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Operational and conduct risks, Government funding dependency, Market competition, Access to capital, Interest rate fluctuations
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [32.10$, 42.55$]
- 2025-12-31 to 2026-12-31 estimated range: [31.48$, 41.84$]
Financial Metrics affecting the UHT estimates:
- Positive: with PPE of 10.7 at the end of fiscal year the price was neutral
- Positive: Operating profit margin, % of 37.16 > 18.47
- Positive: 5.50 < Industry operating cash flow per share per price (median), % of 7.52
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 3.21
- Negative: Investing cash flow per share per price, % of -2.72 <= -0.64
- Negative: -0.75 < Inventory ratio change, % of 0
- Positive: 6.68 < Operating cash flow per share per price, % of 9.18
- Positive: 19.59 < Shareholder equity ratio, % of 30.91 <= 42.74
- Negative: Industry earnings per price (median), % of 3.30 <= 4.52
- Negative: -0.17 < Industry inventory ratio change (median), % of 0
Short-term UHT quotes
Long-term UHT plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $90.62MM | $95.58MM | $99.01MM |
| Operating Expenses | $59.96MM | $64.23MM | $62.22MM |
| Operating Income | $30.67MM | $31.35MM | $36.80MM |
| Non-Operating Income | $-9.56MM | $-15.95MM | $-17.56MM |
| Interest Expense | $10.76MM | $22.03MM | $23.83MM |
| Income(Loss) | $21.10MM | $15.40MM | $19.23MM |
| Profit(Loss)* | $21.10MM | $15.40MM | $19.23MM |
| Stockholders Equity | $229.10MM | $200.93MM | $179.54MM |
| Assets | $607.54MM | $596.37MM | $580.86MM |
| Operating Cash Flow | $46.80MM | $42.94MM | $46.91MM |
| Capital expenditure | $13.62MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-36.67MM | $-19.11MM | $-13.88MM |
| Financing Cash Flow | $-25.02MM | $-23.23MM | $-34.15MM |
| Earnings Per Share** | $1.53 | $1.12 | $1.39 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.